Insider Stock Trading History of Ji Henry


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Ji Henry since year 2005. The trader's CIK number is 1470981. At the time of this reporting, Ji Henry is the See Remarks of Sorrento Therapeutics, Inc. . (stock ticker symbol SRNE). See this page for all insider trading activities at Sorrento Therapeutics, Inc. .


Stock purchases, sales, and option exercises reported by insider Ji Henry since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2018-02-28 SRNE Sorrento Therapeutics, Inc. Buy 64,600 9.95 642,770
2018-01-21 SRNE Sorrento Therapeutics, Inc. Buy 1,801,801 .00 0
2017-06-15 SRNE Sorrento Therapeutics, Inc. Buy 29,001 1.82 52,781
2017-04-19 SRNE Sorrento Therapeutics, Inc. Buy 100,000 2.00 200,000
2017-02-22 SRNE Sorrento Therapeutics, Inc. Buy 2,000 5.60 11,200
2017-02-03 SRNE Sorrento Therapeutics, Inc. Buy 20,000 5.15 103,000
2015-08-26 SRNE Sorrento Therapeutics, Inc. Buy 500 .72 362
2015-08-24 SRNE Sorrento Therapeutics, Inc. Buy 8,888 12.84 114,148
2015-08-21 SRNE Sorrento Therapeutics, Inc. Buy 8,888 13.08 116,219
2014-11-10 SRNE Sorrento Therapeutics, Inc. Buy 5,999 4.82 28,927
2014-11-07 SRNE Sorrento Therapeutics, Inc. Buy 4,000 4.56 18,252
2014-11-06 SRNE Sorrento Therapeutics, Inc. Buy 3,000 4.53 13,575
2013-12-05 SRNE Sorrento Therapeutics, Inc. Buy 1,000 8.91 8,915
2013-12-04 SRNE Sorrento Therapeutics, Inc. Buy 1,000 8.54 8,537
2013-11-22 SRNE Sorrento Therapeutics, Inc. Buy 1,000 8.47 8,466
2013-11-19 SRNE Sorrento Therapeutics, Inc. Buy 2,000 8.60 17,190
2012-05-15 SRNE Sorrento Therapeutics, Inc. Buy 6,250,000 .16 1,000,000

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Ji Henry (See Remarks of Sorrento Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.